PAP Devices Market Size, Share, Forecast, & Trends Analysis by Type [CPAP, BiPAP, APAP, Accessories (Masks, Headgear)], Disease [Obstructive Sleep Apnea, COPD, Respiratory Failure] End User [Hospitals, Home Healthcare Settings] - Global Forecast to 2031

PAP Devices Market Size & Forecast

The PAP Devices Market is projected to reach $6.97 billion by 2031, at a CAGR of 5.2% from 2024 to 2031. The growth of this market is driven by the increasing prevalence of respiratory and sleeping disorders, the rising geriatric population suffering from respiratory disorders, the introduction of new sleep apnea devices, growing awareness about the adverse impacts of untreated sleep apnea, and favorable reimbursement policies for sleep apnea therapies and devices. However, PAP devices are expensive and not suitable for patients with certain conditions, which restrains the market’s growth.

Furthermore, technological advancements in positive airway pressure (PAP) devices and a rising focus on out-of-hospital healthcare are expected to offer significant market growth opportunities. However, the side effects of PAP devices and the low adherence rate for sleep apnea devices are challenging the market’s growth.

PAP Devices Market Growth Drivers

Increasing Prevalence of Respiratory and Sleep Disorders

The prevalence of respiratory diseases is rising globally. Respiratory diseases are mainly caused due to smoking, infections, air pollution, dust, and chemicals. Some of the most common respiratory diseases are Chronic Obstructive Pulmonary Disease (COPD), asthma, lung cancer, pulmonary fibrosis, pneumonia, bronchitis, cystic fibrosis, and emphysema. According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is among the most common causes of mortality worldwide. In 2020, the disorder accounted for approximately 3.23 million deaths, and low and middle-income countries (LMIC) accounted for 90% of COPD deaths among those below the age of 70.

Additionally, sleep disorders include sleep apnea and insomnia and are caused due to hormones, stress, anxiety, and digestive disorders. According to the National Institutes of Health (NIH), in 2021, 50 to 70 million people in the U.S. had chronic sleep disorders, with 40% of adults reportedly falling asleep during the day at least once a month. Thus, the increasing prevalence of respiratory diseases and sleep disorders has increased the adoption of APAP, CPAP, and BiPAP devices.

Click here to: Get Free Sample Pages of this Report

Increasing Geriatric Population Suffering from Respiratory Disorders

The aging population is on the rise due to increased life expectancy, improved healthcare, urbanization, and higher income levels, resulting in better survival rates. Aging brings about significant structural changes in the respiratory system, making elderly individuals more susceptible to respiratory diseases. Common symptoms include cough, asthma, COPD, sleep-disordered breathing, and dyspnea, necessitating a systematic approach to diagnosis.

However, elderly patients often face misdiagnosis and improper treatment for respiratory disorders. According to the United Nations, the global proportion of people aged 65 and older is projected to increase from 10% in 2022 to 16% in 2050. Significant annual increases in the elderly population are expected in Northern Africa, Western Asia, Sub-Saharan Africa, Oceania (excluding Australia and New Zealand), and Central and Southern Asia between 2022 and 2050.

Furthermore, according to data published by the World Health Organization (WHO) in 2022, by 2030, one in every six people globally will be 60 years or older, with the population aged 60 and above expected to grow from 1 billion in 2020 to 1.4 billion by 2030, and to 2.1 billion by 2050. This demographic shift will lead to a higher prevalence of respiratory disorders among the elderly, increasing the demand for PAP devices.

PAP Devices Market Opportunities

Technological Advancements in PAP Devices

Prescription or over-the-counter sleep aids and cognitive behavioral therapy for insomnia (CBT-I) are common treatments for people with sleep insomnia and other sleep disorders. However, neither is completely suitable for many patients. Pharmaceuticals have negative effects and result in addiction, and in many parts of the world, trained cognitive behavioral therapy (CBT-I) clinicians are unavailable or do not have timely appointment availability.

Technological advancements in sleep apnea devices have enabled quieter built-in humidification systems and comfort features, including expiratory pressure modulation, inspiratory support, and pressure ramping. Several PAP technologies have been developed to allow patients to participate in their own care by monitoring adherence. For instance, a PAP device can display the previous night's usage and deliver real-time feedback and guidance.

Thus, technological advancements in PAP devices are creating market growth opportunities.

Rising Preference for Out-of-Hospital Healthcare

The preference for out-of-hospital healthcare is rising, particularly evident in the shift of PAP therapy from traditional sleep clinics and hospitals to home settings. Historically, patients underwent overnight sleep studies in clinical environments to diagnose and manage sleep apnea. However, outpatient treatment is often more cost-effective compared to inpatient care, saving patients on expenses such as overnight stays and hospital bills.

PAP devices allow patients to receive treatment conveniently at home, eliminating the need to stay in unfamiliar hospital surroundings. This setup can improve sleep quality and enhance overall treatment adherence. Moreover, the advent of portable PAP devices has empowered patients to self-manage conditions like sleep apnea more effectively. These devices are compact, user-friendly, and equipped with wireless capabilities for data tracking and remote adjustments.

PAP Devices Market Trends

Integration of Smart Features in PAP Devices

The integration of smart features into PAP devices necessitates a combination of advanced software and hardware components. These devices utilize sophisticated sensors and algorithms to continuously gather data during sleep, which is then presented and analyzed in a user-friendly format.

Furthermore, smart features in PAP devices provide real-time monitoring of mask seal integrity to optimize therapy effectiveness. They also monitor sleep patterns and treatment adherence, enabling the identification of trends and detection of irregularities. This capability facilitates the development of personalized and effective treatment plans, ultimately enhancing patient outcomes.

PAP Devices Market Analysis: Key Findings

By Product: In 2024, the Continuous Positive Airway Pressure (CPAP) Devices Segment to Dominate the PAP Devices Market

Based on product, the PAP devices market is segmented into Continuous Positive Airway Pressure (CPAP) devices, Bilevel Positive Airway Pressure (BiPAP) devices, Automatic Positive Airway Pressure (APAP) devices, and accessories. In 2024, the continuous positive airway pressure (CPAP) devices segment is expected to account for the largest share of 68.2% of the PAP devices market. The segment’s large market share is attributed to the availability of advanced noiseless CPAP machines with compact designs and advanced interfaces, technological advancements in PAP devices, and the rising availability & accessibility of new CPAP devices. Additionally, rising healthcare expenditures and increasing disposable incomes in emerging countries are driving the adoption of PAP devices.

By Application: the Obstructive Sleep Apnea (OSA) Segment to Dominate the PAP Devices Market

Based on application, the PAP devices market is segmented into Obstructive Sleep Apnea (OSA), respiratory failure, Chronic Obstructive Pulmonary Disease (COPD), and heart failure. In 2024, the obstructive sleep apnea (OSA) segment is expected to account for the largest share of the PAP devices market. The segment’s large market share is attributed to the introduction of products for treating obstructive sleep apnea. For instance, in August 2021, ResMed Inc. (U.S.) launched the AirSense 11 PAP Series of devices to manage and treat obstructive sleep apnea. Also, in September 2021, Sommetrics, Inc. (U.S.) ran clinical trials of the aerSleep II device developed for the treatment of obstructive sleep apnea.

By End User: the Hospitals & Sleep Clinics Segment to Dominate the PAP Devices Market

Based on end user, the PAP devices market is segmented into hospitals & sleep clinics and home healthcare settings. In 2024, the hospitals & sleep clinics segment is expected to account for the largest share of 60.9% of the PAP devices market. The large market share of this segment is attributed to the rising prevalence of sleep apnea. According to the National Institutes of Health (NIH), in 2020, 936 million adults aged 30–69 suffered from mild to severe obstructive sleep apnea (OSA), and 425 million adults aged 30–69 suffered from moderate to severe obstructive sleep apnea globally.

Geographical Analysis

By Geography: In 2024, North America to Dominate the PAP Devices Market

In 2024, North America is expected to account for the largest share of 41.5% of the PAP devices market, followed by Europe and Asia-Pacific. North America’s significant market share can be attributed to the growing awareness about the adverse impacts of untreated sleep apnea, increasing prevalence of respiratory and sleep disorders, and the presence of major PAP devices companies such as ResMed Inc. (U.S.), Rotech Healthcare Inc. (U.S.), and Cardinal Health, Inc. (U.S.).

However, the market in Asia-Pacific is projected to register the highest growth rate of 5.7% during the forecast period. The growth of this regional market can be attributed to the increasing government spending on healthcare in countries such as China, India, Singapore, and South Korea, technological advancements in PAP devices, and increasing government initiatives to promote awareness. Furthermore, government initiatives supporting the development of healthcare facilities and increasing awareness about sleep disorders and respiratory disorders contribute to the growth of this regional market.

PAP Devices Market: Key Companies

The report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios and geographic presence and the key growth strategies adopted by them over the past 3–4 years. Some of the key players operating in the PAP devices market are ResMed Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Inspire Medical Systems, Inc. (U.S.), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Rotech Healthcare Inc. (U.S.), Cardinal Health, Inc. (U.S.), Invacare Corporation (U.S.), Cleveland Medical Devices Inc. (U.S.), BMC Medical Co., Ltd. (China), Löwenstein Medical Technology GmbH + Co. KG. (Germany), SomnoMed, Inc. (Australia), Drive DeVilbiss Healthcare Ltd. (U.S.), and SunMed, LLC (U.S.)

PAP Devices Industry Overview: Latest Developments from Key Industry Players

• In March 2024, ResMed Inc. (U.S.) launched the AirFit F40 ultra-compact, full-face mask for sleep apnea.

• In February 2024, ResMed Inc. (U.S.) launched the AirCurve 11 device, a new bi-level sleep apnea device, as a CPAP alternative to treat patients with sleep apnea.

• In August 2021, ResMed Inc. (U.S.) launched AirSense, a next-generation positive airway pressure (PAP) device to provide specific guidance to PAP users and assist them ease into therapy with ease of nightly use for treating obstructive sleep apnea.

PAP Devices Market Research Summary

Key questions answered in the PAP devices market report: